Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Smith

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Journal of Translational Medicine|April 13, 2018
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary interventionLarisa H Cavallari, Francesco Franchi, Fabiana Rollini, et al.
Clinical Pharmacology and Therapeutics|January 31, 2025
A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical PracticeTeresa T Ho, D Max Smith, Christina L Aquilante, et al.
The Pharmacogenomics Journal|June 2, 2021
Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux diseaseAmanda L Elchynski, Emily J Cicali, Maria C Ferrer Del Busto, et al.
Clinical and Translational Science|February 8, 2025
A Randomized Hybrid-Effectiveness Trial Comparing Pharmacogenomics (PGx) to Standard Care: The PGx Applied to Chronic Pain Treatment in Primary Care (PGx-ACT) TrialD Max Smith, Rut Beyene, Paul Kolm, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 4, 2005
Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathyY Joseph Woo, Todd J Grand, Mark F Berry, et al.
Clinical and Translational Science|January 20, 2018
Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons LearnedKristin W Weitzel, D Max Smith, Amanda R Elsey, et al.
Research Square|August 26, 2024
Pharmacokinetics and Pharmacogenomics of Ribociclib in Black Patients with Metastatic Breast Cancer: The LEANORA studySandra Swain, Ilana Schlam, D Max Smith, et al.
Clinical and Translational Science|December 28, 2025
Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine TherapyNihal El Rouby, Christina L Aquilante, Salma A Bargal, et al.
Clinical Pharmacology and Therapeutics|June 12, 2023
An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare ProvidersAkinyemi Oni-Orisan, Sony Tuteja, Glenda Hoffecker, et al.
Leukemia|July 13, 2026
Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasmsAnna B Halpern, Megan Othus, Mary-Elizabeth M Percival, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of Translational Medicine|April 13, 2018
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary interventionLarisa H Cavallari, Francesco Franchi, Fabiana Rollini, et al.
Clinical Pharmacology and Therapeutics|January 31, 2025
A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical PracticeTeresa T Ho, D Max Smith, Christina L Aquilante, et al.
The Pharmacogenomics Journal|June 2, 2021
Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux diseaseAmanda L Elchynski, Emily J Cicali, Maria C Ferrer Del Busto, et al.
Clinical and Translational Science|February 8, 2025
A Randomized Hybrid-Effectiveness Trial Comparing Pharmacogenomics (PGx) to Standard Care: The PGx Applied to Chronic Pain Treatment in Primary Care (PGx-ACT) TrialD Max Smith, Rut Beyene, Paul Kolm, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 4, 2005
Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathyY Joseph Woo, Todd J Grand, Mark F Berry, et al.
Clinical and Translational Science|January 20, 2018
Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons LearnedKristin W Weitzel, D Max Smith, Amanda R Elsey, et al.
Research Square|August 26, 2024
Pharmacokinetics and Pharmacogenomics of Ribociclib in Black Patients with Metastatic Breast Cancer: The LEANORA studySandra Swain, Ilana Schlam, D Max Smith, et al.
Clinical and Translational Science|December 28, 2025
Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine TherapyNihal El Rouby, Christina L Aquilante, Salma A Bargal, et al.
Clinical Pharmacology and Therapeutics|June 12, 2023
An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare ProvidersAkinyemi Oni-Orisan, Sony Tuteja, Glenda Hoffecker, et al.
Leukemia|July 13, 2026
Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasmsAnna B Halpern, Megan Othus, Mary-Elizabeth M Percival, et al.
Pageof 5